Market Tracker

04/28 5:16pm ET

Amgen Inc (NASDAQ:AMGN)

163.32
Delayed Data
As of Apr 28
 +0.60 / +0.37%
Today’s Change
133.64
Today|||52-Week Range
184.21
+11.70%
Year-to-Date
Burt Wealth Advisors Buys International Business Machines, Canadian National Railway ...
Apr 28 / GuruFocus News - Paid Partner Content
Amgen Reports 1st-Quarter Earnings Results
Apr 27 / GuruFocus News - Paid Partner Content
Verity & Verity, LLC Buys Watsco, Chevron, Exxon Mobil, Sells British American Tobacc...
Apr 28 / GuruFocus News - Paid Partner Content
Amgen (AMGN) Q1 Earnings Top, Sales Miss, Shares Decline
Apr 27 / Zacks.com - Paid Partner Content
Sanofi (SNY) Q1 Earnings Top, Sales Rise Y/Y, Shares Up
Apr 28 / Zacks.com - Paid Partner Content
Early-Morning Earnings Extravaganza
Apr 27 / TheStreet.com - Paid Partner Content
DUPONT CAPITAL MANAGEMENT Corp Buys Energy XXI Gulf Coast, Chevron, Johnson & Johnson...
Apr 27 / GuruFocus News - Paid Partner Content
Stocks Dazed After Trump NAFTA Flop, Tax Plan Disappointment; ECB Looms
Apr 27 / Investing Channel - Paid Partner Content
The 4 Principles That Drive PRIMECAP
Apr 27 / GuruFocus News - Paid Partner Content
Amgen Reports Mixed Financials Results as Its Lead Drug, Enbrel, Sees Sales Decrease
Apr 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close162.72
Today’s open162.39
Day’s range161.53 - 163.48
Volume2,942,158
Average volume (3 months)3,687,908
Market cap$120.1B
Dividend yield2.82%
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.18%
Earnings growth (next 5 years)+6.44%
Revenue growth (last year)+6.31%
P/E ratio15.9
Price/Sales4.86
Price/Book4.04

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.03-0.04%
BIIBBiogen-5.36-1.94%
ILMNIllumina Inc+1.12+0.61%
BIVVBioverativ Inc+0.72+1.24%
Data as of 4:14pm ET, 04/28/2017

Financials

Last reporting dateApril 26, 2017
EPS forecast (this quarter)$2.99
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts